2019
DOI: 10.1016/j.bioorg.2018.12.028
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
33
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 116 publications
(43 citation statements)
references
References 42 publications
3
33
0
Order By: Relevance
“…[7,67] Preferred AChE inhibitors for treating AD are inhibitors that increase the activity of cholinergic neurotransmission by increasing the amount of ACh. [68,69] As the most potent inhibitor, the long-acting tacrine (IC 50 : 8.18 nM; K i : 8.59 ± 5.38 nM) compound has a hepatotoxic effect. In particular, it was found that the liver enzyme increases alanine transaminase level.…”
Section: Resultsmentioning
confidence: 99%
“…[7,67] Preferred AChE inhibitors for treating AD are inhibitors that increase the activity of cholinergic neurotransmission by increasing the amount of ACh. [68,69] As the most potent inhibitor, the long-acting tacrine (IC 50 : 8.18 nM; K i : 8.59 ± 5.38 nM) compound has a hepatotoxic effect. In particular, it was found that the liver enzyme increases alanine transaminase level.…”
Section: Resultsmentioning
confidence: 99%
“…As of now, there is no FDA-recognized adjuvant therapy for this outcome [6]. In this vein, several compounds, especially derivatives of β-amino carbonyl and pyrazoline benzensulfonamides, have been considered as in vitro cytotoxicity-enhancing drug candidates and also CA inhibitor candidates in OSCC cell lines (i.e., Ca9-22, HSC-2, HSC-3, and HSC-4) [43,44,45].…”
Section: Resultsmentioning
confidence: 99%
“…This enzyme terminates nerve conduction by hydrolyzing acetylcholine (ACh) to acetic acid and choline (Ch) in the cholinergic synapses of the nervous system, somatic system, and central nervous system. The AChE inhibitors are clinically used for the treatment of AD, which increase cholinergic functions in cholinergic synapses …”
Section: Introductionmentioning
confidence: 99%